Bradley Miller
Financieel Directeur/CFO bij Yale Pharmaceuticals, Inc.
Vermogen: 762 774 $ op 30-04-2024
Profiel
Bradley J.
Miller is currently working as the Chief Financial Officer & Executive Vice President at Yale Pharmaceuticals, Inc.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 25-03-2024 | 244 479 ( 0.32% ) | 762 774 $ | 30-04-2024 |
Actieve functies van Bradley Miller
| Bedrijven | Functie | Begin |
|---|---|---|
Yale Pharmaceuticals, Inc.
 Yale Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Yale Pharmaceuticals, Inc. is a minority-owned business which provides pharmaceutical and health care products. The firm's product categories include gastrointestinal, diagnostics, baby care, cardiology, dental diabetes care, oncology, and orthopedics. It offers pharmaceutical related research, including drug screening, target identification and validation, clinical trial studies, and consulting services. The company was founded in 2005 and is located in Frederick, MD. | Financieel Directeur/CFO | 22-05-2009 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Yale Pharmaceuticals, Inc.
Yale Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Yale Pharmaceuticals, Inc. is a minority-owned business which provides pharmaceutical and health care products. The firm's product categories include gastrointestinal, diagnostics, baby care, cardiology, dental diabetes care, oncology, and orthopedics. It offers pharmaceutical related research, including drug screening, target identification and validation, clinical trial studies, and consulting services. The company was founded in 2005 and is located in Frederick, MD. | Health Technology |
